10x Genomics, Inc. TXG Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$13.47M+17.1% | -$16.25M+40.8% | -$27.47M-180% | $34.54M+201% | -$34.36M+29.9% | ||
| $9.96M-1.1% | $10.07M-2.3% | $10.3M+31.8% | $7.82M-2.6% | $8.02M-8.3% | ||
| $22.64M-10.2% | $25.22M-0.2% | $25.26M-8.3% | $27.56M-11.3% | $31.08M-4.5% | ||
| $26.12M-35.9% | $40.78M-5.6% | $43.21M+144% | $17.71M-48.4% | $34.35M— | ||
| $1.6M-10.1% | $1.78M+159% | $687K-56.5% | $1.58M-16.6% | $1.89M-30.3% | ||
| -$1.31M+27.4% | -$1.81M+79.5% | -$8.8M-837% | -$939K+50.4% | -$1.89M+96.3% | ||
| -$8.42M-475% | $2.24M+263% | $617K-82.5% | $3.52M+735% | $422K-90.7% | ||
| $16.32M-60.4% | $41.26M+17.9% | $35M+69.5% | $20.65M-37.4% | $32.99M+161% | ||
| $24.52M-37.1% | $39M-8.3% | $42.53M+164% | $16.13M-50.3% | $32.46M+443% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does 10x Genomics, Inc.'s cash flow data come from?
- Every line is extracted from 10x Genomics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.